Should I buy or sell MDxHealth stock right now?

4 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for MDxHealth in the last twelve months. There are currently 4 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" MDXH shares. View MDXH analyst ratings or view top-rated stocks .

What is MDxHealth's stock price target for 2024?

4 Wall Street analysts have issued 12-month target prices for MDxHealth's shares. Their MDXH share price targets range from $7.00 to $70.00. On average, they predict the company's share price to reach $28.33 in the next year. This suggests a possible upside of 1,170.6% from the stock's current price. View analysts price targets for MDXH or view top-rated stocks among Wall Street analysts .

How have MDXH shares performed in 2024?

MDxHealth's stock was trading at $3.94 at the start of the year. Since then, MDXH stock has decreased by 43.4% and is now trading at $2.23. View the best growth stocks for 2024 here .

Are investors shorting MDxHealth?

MDxHealth saw a drop in short interest in the month of March. As of March 31st, there was short interest totaling 17,100 shares, a drop of 26.9% from the March 15th total of 23,400 shares. Based on an average trading volume of 84,000 shares, the short-interest ratio is presently 0.2 days. Currently, 0.1% of the company's stock are short sold. View MDxHealth's Short Interest .

When is MDxHealth's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, June 5th 2024. View our MDXH earnings forecast .

How were MDxHealth's earnings last quarter?

MDxHealth SA (NASDAQ:MDXH) released its quarterly earnings data on Wednesday, March, 6th. The company reported ($0.39) earnings per share for the quarter. The business earned $19.40 million during the quarter.

When did MDxHealth's stock split?

MDxHealth shares reverse split on the morning of Friday, December 29th 2023. The 1-10 reverse split was announced on Monday, October 2nd 2023. The number of shares owned by shareholders was adjusted after the market closes on Thursday, December 28th 2023. An investor that had 100 shares of stock prior to the reverse split would have 10 shares after the split.

What guidance has MDxHealth issued on next quarter's earnings?

MDxHealth issued an update on its FY 2024 earnings guidance on Wednesday, March, 6th. The company provided EPS guidance of for the period. The company issued revenue guidance of $79.0 million-$81.0 million, compared to the consensus revenue estimate of $79.6 million.

When did MDxHealth IPO?

MDxHealth (MDXH) raised $45 million in an initial public offering on Thursday, November 4th 2021. The company issued 3,750,000 shares at $12.00 per share.

How do I buy shares of MDxHealth?

Shares of MDXH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here .

NASDAQ:MDXH

MDxHealth (MDXH) Stock Price, News & Analysis

→ Urgent alert: open this for a huge profit potential (From Timothy Sykes) (Ad)

Free MDXH Stock Alerts

$2.23

-0.06 (-2.62%)

(As of 04/19/2024 ET)

Compare

Today's Range: $2.21
▼
$2.28
50-Day Range: $2.23
▼
$3.78
52-Week Range: $2.15
▼
$4.64

Volume: 30,660 shs
Average Volume: 80,085 shs
Market Capitalization: N/A

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: $28.33

Get MDxHealth alerts:

MDxHealth MarketRank™ Stock Analysis

Analyst Rating: Buy
3.00 Rating Score
Upside/Downside: 1,170.6% Upside
$28.33 Price Target
Short Interest: Healthy
0.12% of Float Sold Short
Dividend Strength: N/A
Sustainability: N/A
News Sentiment: N/A
Insider Trading: N/A
Proj. Earnings Growth: Growing
From ($1.02) to ($0.75) Per Share

Overall MarketRank^™

New Rank-Based ScoringMarketRank^™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

2.18 out of 5 stars

3.5

Analyst's Opinion

Consensus Rating
MDxHealth has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 4 buy ratings, no hold ratings, and no sell ratings.
Amount of Analyst Coverage
MDxHealth has only been the subject of 3 research reports in the past 90 days.

5.0

Short Interest

Percentage of Shares Shorted
0.12% of the float of MDxHealth has been sold short.
Short Interest Ratio / Days to Cover
MDxHealth has a short interest ratio ("days to cover") of 0.2, which is generally considered an acceptable ratio of short interest to trading volume.
Change versus previous month
Short interest in MDxHealth has recently decreased by 26.92%, indicating that investor sentiment is improving significantly.

0.0

Dividend Strength

Dividend Yield
MDxHealth does not currently pay a dividend.
Dividend Growth
MDxHealth does not have a long track record of dividend growth.

N/A

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score
There is no current Upright™ data available for MDXH.

0.6

News and Social Media Coverage

Search Interest
6 people have searched for MDXH on MarketBeat in the last 30 days.
MarketBeat Follows
Only 1 people have added MDxHealth to their MarketBeat watchlist in the last 30 days. This is a decrease of -50% compared to the previous 30 days.

0.0

Company Ownership

Insider Buying vs. Insider Selling
In the past three months, MDxHealth insiders have not sold or bought any company stock.
Percentage Held by Insiders
Only 1.70% of the stock of MDxHealth is held by insiders.

1.3

Earnings and Valuation

Earnings Growth
Earnings for MDxHealth are expected to grow in the coming year, from ($1.02) to ($0.75) per share.
Price to Book Value per Share Ratio
MDxHealth has a P/B Ratio of 0.37. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

Ad Timothy Sykes

Urgent alert: open this for a huge profit potential

This groundbreaking technology that Tim calls “Inception” isn’t being talked about anywhere… not on Fox, Yahoo, or CNBC.

See Tim’s instructions to make this remarkably simple trade right here

About MDxHealth Stock (NASDAQ:MDXH)

MDxHealth SA, a commercial-stage precision diagnostics company, provides urologic solutions in the United States, Europe, and internationally. Its novel prostate cancer genomic testing solutions are SelectMDx, a non-invasive urine test; and ConfirmMDx, an epigenetic test, which provide physicians with a clinical pathway to identify clinically prostate cancer while minimizing the use of invasive procedures that are prone to complications. The company was formerly known as OncoMethylome Sciences SA and changed its name to MDxHealth SA in October 2010. MDxHealth SA was incorporated in 2003 and is headquartered in Herstal, Belgium.

MDXH Stock Price History

30 days | 90 days | 365 days | Advanced Chart

MDXH Stock News Headlines

April 4, 2024 | finance.yahoo.com

Notice convening the Annual General Meeting in BioPorto A/S

March 12, 2024 | globenewswire.com

Mdxhealth Adds Hereditary Prostate Cancer Genetic Test to Prostate Cancer Offering

April 19, 2024 | Timothy Sykes (Ad)

Urgent alert: open this for a huge profit potential

This groundbreaking technology that Tim calls “Inception” isn’t being talked about anywhere… not on Fox, Yahoo, or CNBC.

March 11, 2024 | markets.businessinsider.com

Analysts Conflicted on These Healthcare Names: MDxHealth (MDXH), OrthoPediatrics (KIDS) and Karuna Therapeutics (KRTX)

March 7, 2024 | markets.businessinsider.com

Buy Rating Affirmed for MDxHealth Amid Strong Q4 Performance and Positive Future Outlook

March 6, 2024 | globenewswire.com

Mdxhealth Announces Fourth Quarter and Full-Year 2023 Financial Results

February 21, 2024 | finance.yahoo.com

MDxHealth to Present Fourth Quarter and Full Year 2023 Financial Results and Corporate Update on March 6

February 21, 2024 | finance.yahoo.com

MDxHealth to Present Fourth Quarter and Full Year 2023 Financial Results and Corporate Update on March 6

April 19, 2024 | Timothy Sykes (Ad)

Urgent alert: open this for a huge profit potential

This groundbreaking technology that Tim calls “Inception” isn’t being talked about anywhere… not on Fox, Yahoo, or CNBC.

February 21, 2024 | globenewswire.com

MDxHealth to Present Fourth Quarter and Full Year 2023 Financial Results and Corporate Update on March 6

February 16, 2024 | globenewswire.com

Mdxhealth Announces Resignation of Board Member

January 8, 2024 | finance.yahoo.com

MDxHealth Reports Preliminary Fourth Quarter and Full Year 2023 Revenues and Issues 2024 Revenue Guidance

December 18, 2023 | finance.yahoo.com

MDxHealth Announces Completion of Transition to Single Listing on Nasdaq

November 15, 2023 | lse.co.uk

Mdxhealth Share Price (MDXH.BR)

November 13, 2023 | finance.yahoo.com

MDxHealth Announces Completion of Share Consolidation, and Update of Outstanding Shares and Voting Rights

November 8, 2023 | msn.com

MDxHealth SA GAAP EPS of -$0.04, revenue of $19.35M beats by $1.05M

November 8, 2023 | finance.yahoo.com

MDxHealth Reports Results for the Third Quarter and Nine-Month Period Ended September 30, 2023

November 6, 2023 | finance.yahoo.com

MDxHealth Announces the Approval by its Shareholders of the Proposed Transition to a Sole Listing of Shares on Nasdaq, and Details of the Share Consolidation

October 25, 2023 | finance.yahoo.com

MDxHealth to Present Third Quarter 2023 Financial Results and Corporate Update on November 8

October 19, 2023 | finance.yahoo.com

MDxHealth SA Sponsored ADR (MDXH) Expected to Beat Earnings Estimates: Should You Buy?

October 10, 2023 | finanznachrichten.de

mdxhealth: MDxHealth Reports Preliminary Q3-2023 Revenues

October 10, 2023 | markets.businessinsider.com

Analysts Are Bullish on These Healthcare Stocks: Terns Pharmaceuticals (TERN), MDxHealth S.A. Sponsored ADR (MDXH)

October 4, 2023 | finanznachrichten.de

mdxhealth: MDxHealth Announces Proposed Transition to a Sole Listing of Shares on Nasdaq and Convenes an Extraordinary General Shareholders Meeting

September 26, 2023 | finance.yahoo.com

Mdxhealth Signs Research Collaboration with University of Oxford to Assess the Correlation of the GPS Test with Prostate Cancer Progression Following Treatment for Localized Prostate Cancer

August 29, 2023 | markets.businessinsider.com

BTIG Sticks to Its Buy Rating for MDxHealth S.A. Sponsored ADR (MDXH)

August 23, 2023 | finance.yahoo.com

MDxHealth Reports Q2 and Half Year 2023 Results

August 23, 2023 | finance.yahoo.com

MDxHealth SA Sponsored ADR (MDXH) Reports Q2 Loss, Tops Revenue Estimates

See More Headlines

Receive MDXH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for MDxHealth and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings: 3/06/2024
Today: 4/19/2024
Next Earnings (Estimated): 6/05/2024
Fiscal Year End: 12/31/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Sector: Medical
Industry: Private households
Sub-Industry: N/A
Current Symbol: NASDAQ:MDXH
CUSIP: N/A
CIK: 1872529
Web: mdxhealth.com
Phone: 324-364-2070
Fax: 32042597875
Employees: 252
Year Founded: N/A

Price Target and Rating

Average Stock Price Target: $28.33
High Stock Price Target: $70.00
Low Stock Price Target: $7.00
Potential Upside/Downside: +1,170.6%
Consensus Rating: Buy
Rating Score (0-4): 3.00
Research Coverage: 4 Analysts

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: N/A
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: N/A
Return on Assets: N/A

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: N/A
Quick Ratio: N/A

Sales & Book Value

Annual Sales: $70.19 million
Price / Sales: N/A
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: $5.97 per share
Price / Book: 0.37

Miscellaneous

Outstanding Shares: N/A
Free Float: N/A
Market Cap: N/A
Optionable: Not Optionable
Beta: N/A

7 Stocks to Own Before the 2024 Election

Looking to avoid the hassle of mudslinging, volatility, and uncertainty? You'd need to be out of the market, which isn’t viable. So where should investors put their money? Find out with this report.

Get This Free Report

Key Executives

Mr. Michael K. McGarrity (Age 61)
CEO & Executive Director
Comp: $566.5k
Mr. Ron Kalfus (Age 50)
Chief Financial Officer
Mr. Joseph Sollee (Age 59)
Executive VP of Corporate Development & General Counsel
Mr. John A. Bellano (Age 55)
Chief Commercial Officer
Ms. Miriam Reyes (Age 51)
Executive Vice President of Operations
Dr. Jason Poole Ph.D.
Chief Scientific Officer

Key Competitors

View All Competitors

Institutional Ownership

View All Institutional Transactions

MDXH Stock Analysis - Frequently Asked Questions

Should I buy or sell MDxHealth stock right now?: 4 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for MDxHealth in the last twelve months. There are currently 4 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" MDXH shares.
View MDXH analyst ratings or view top-rated stocks.
What is MDxHealth's stock price target for 2024?: 4 Wall Street analysts have issued 12-month target prices for MDxHealth's shares. Their MDXH share price targets range from $7.00 to $70.00. On average, they predict the company's share price to reach $28.33 in the next year. This suggests a possible upside of 1,170.6% from the stock's current price.
View analysts price targets for MDXH or view top-rated stocks among Wall Street analysts.
How have MDXH shares performed in 2024?: MDxHealth's stock was trading at $3.94 at the start of the year. Since then, MDXH stock has decreased by 43.4% and is now trading at $2.23.
View the best growth stocks for 2024 here.
Are investors shorting MDxHealth?: MDxHealth saw a drop in short interest in the month of March. As of March 31st, there was short interest totaling 17,100 shares, a drop of 26.9% from the March 15th total of 23,400 shares. Based on an average trading volume of 84,000 shares, the short-interest ratio is presently 0.2 days. Currently, 0.1% of the company's stock are short sold.
View MDxHealth's Short Interest.
When is MDxHealth's next earnings date?: The company is scheduled to release its next quarterly earnings announcement on Wednesday, June 5th 2024.
View our MDXH earnings forecast.
How were MDxHealth's earnings last quarter?: MDxHealth SA (NASDAQ:MDXH) released its quarterly earnings data on Wednesday, March, 6th. The company reported ($0.39) earnings per share for the quarter. The business earned $19.40 million during the quarter.

When did MDxHealth's stock split?: MDxHealth shares reverse split on the morning of Friday, December 29th 2023. The 1-10 reverse split was announced on Monday, October 2nd 2023. The number of shares owned by shareholders was adjusted after the market closes on Thursday, December 28th 2023. An investor that had 100 shares of stock prior to the reverse split would have 10 shares after the split.
What guidance has MDxHealth issued on next quarter's earnings?: MDxHealth issued an update on its FY 2024 earnings guidance on Wednesday, March, 6th. The company provided EPS guidance of for the period. The company issued revenue guidance of $79.0 million-$81.0 million, compared to the consensus revenue estimate of $79.6 million.
When did MDxHealth IPO?: MDxHealth (MDXH) raised $45 million in an initial public offering on Thursday, November 4th 2021. The company issued 3,750,000 shares at $12.00 per share.
How do I buy shares of MDxHealth?: Shares of MDXH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:MDXH) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

MDxHealth (MDXH) Stock Price, News & Analysis

MDxHealth MarketRank™ Stock Analysis

Overall MarketRank™

Analyst's Opinion

Short Interest

Percentage of Shares Shorted

Short Interest Ratio / Days to Cover

Change versus previous month

Dividend Strength

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score

News and Social Media Coverage

Search Interest

MarketBeat Follows

Company Ownership

Earnings and Valuation

About MDxHealth Stock (NASDAQ:MDXH)

MDXH Stock Price History

MDXH Stock News Headlines

Company Calendar

Industry, Sector and Symbol

Price Target and Rating

Profitability

Debt

Sales & Book Value

Miscellaneous

Key Executives

Key Competitors

Institutional Ownership

MDXH Stock Analysis - Frequently Asked Questions

Overall MarketRank^™